News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Pan-RAS Inhibitor Shows Early, Deep Molecular Responses in PDAC
the-express.com
Jan 26, 2025, 17:30

Pan-RAS Inhibitor Shows Early, Deep Molecular Responses in PDAC

Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X:

“Pan-RAS inhibitor Daraxonrasib in 2L of pancreatic cancer

ORR KRAS G12X: 36%, RAS mt: 27%

For comparison ORR with nal-IRI-FU/LV in NAPOLI-1: 7.7%.”

Pan-RAS Inhibitor Shows Early, Deep Molecular Responses in PDAC

Additional information.

ASCOGI25 cancer Erman Akkus OncoDaily Oncology
Special Coverage
Blog
Jan 26, 2025, 17:30
Pan-RAS Inhibitor Shows Early, Deep Molecular Responses in PDAC
Blog
Jan 26, 2025, 17:23
Trisha Lal: Day 1 of ASCOGI25
Blog
Jan 26, 2025, 17:19
The role of social media in oncology presented by Prof. Gevorg Tamamyan
Career
Jan 26, 2025, 17:14
Daniel Anaya: Jason Denbo was appointed as Moffitt Cancer Center's new Head of Hepatobiliary Section
Insight
Jan 26, 2025, 17:12
Pancreatic cancer remains the 3rd leading cause of cancer death in the US - CA: A Cancer Journal for Clinicians
Blog
Jan 26, 2025, 17:08
Shivani Modi: To Treat or Not To Treat - Adjuvant therapy for resectable HCC
Blog
Jan 26, 2025, 17:02
Percy Lee: Appreciate the invite to the 2025 Society of Thoracic Surgery Annual Meeting
Societies
Jan 26, 2025, 16:40
20 Posts Not To Miss from Day 3 of ASCOGI25
Insight
Jan 26, 2025, 16:14
Acute Toxicity and 90-Day Mortality in Stage I NSCLC Patients Treated with SBRT - ESTRO
Insight
Jan 26, 2025, 16:11
Insights from ASCOGI25 by Udhayvir Grewal
Blog
Jan 26, 2025, 16:00
Cindy Pabon: EORTC-1203 GITC "INNOVATION" presented at ASCO GI 2025
Dialogues
Jan 26, 2025, 15:49
BGICC25 Updates: Dr. Mansoor Raza Mirza on Endometrial Cancer Advances